Researchers release the brakes on the immune system

October 18, 2017, University of Bonn
(from left) These are the researchers analyzing the immunological data. Credit: (c) Volker Lannert/Uni Bonn

Many tumors possess mechanisms to avoid destruction by the immune system. For instance, they misuse the natural "brakes" in the immune defense mechanism that normally prevent an excessive immune response. Researchers at the University of Bonn have now been able to remove one of these brakes. The study, which involved colleagues from Hamburg and Würzburg, could pave the way for more effective cancer therapies. It is published in the journal Cell Reports.

Killer T are a powerful weapon of the immune system. Following a viral infection, they swarm out in huge numbers and destroy all of the . Their destructive power is also directed towards cells—at least in principle. Many tumors have actually developed mechanisms that allow them to outmaneuver this defensive weapon. To do this, they can exploit the so-called regulatory T cells. These are also part of the immune system, but fulfill an opposite function: They suppress the immune response and thus prevent killer T cells from attacking healthy tissues.

Tumors exploit this mechanism by pretending to be normal body tissue. They can thus be protected to a certain degree by the regulatory T cells. "We have now found a way to kill off the regulatory T cells," explains Christoph Heuser, a doctoral candidate at the Institute of Experimental Immunology at the University of Bonn. "We were thus able to significantly increase the impact of the killer T cells."

The study focuses on a protein produced naturally in the body called IKKβ, which is known to promote the activation of . It is thus considered an immunostimulant. "We have now blocked IKKβ in a test tube with the help of a pharmaceutical ingredient," says Heuser's colleague Dr. Janine Gotot. "The regulatory T cells died off afterward. However, the killer T cells survived and even gained in impact because they were no longer inhibited by the regulatory T cells."

The researchers then tested mice with skin cancer to see whether the IKKß inhibitor would be suitable for treatment. This cancer is currently treated by vaccination and immunotherapies, but these measures are often ineffective. However, the researchers treated the rodents with the IKKß inhibitor shortly after the vaccination. Following around two weeks of treatment, the number of regulatory T cells fell by half. The response of the killer T cells to the tumor was correspondingly stronger. Cancer growth was delayed significantly, and the animals survived for longer.

Combination therapy against tumors

"Nevertheless, complete healing cannot be achieved solely by inhibiting IKKß," said Prof. Christian Kurts, director of the Institute of Experimental Immunology at the University of Bonn. "By combining with other immunological , it may, however, be possible to stimulate the immune system to more effectively combat the cancer."

The regulatory T cells are only one element among many others with which the body keeps its immune cells in check. Experts also refer to these braking mechanisms as "immunological checkpoints." In recent years, the researchers have succeeded in releasing these brakes using suitable inhibiting substances (the "checkpoint inhibitors"). "This approach has already revolutionized the treatment of cancer," says Kurts.

Explore further: Cancer immunotherapy may get a boost by disabling specific T cells

More information: Prolonged IKKβ inhibition improves ongoing CTL antitumor responses by incapacitating regulatory T cells, Cell Reports (2017). DOI: 10.1016/j.celrep.2017.09.082

Related Stories

Cancer immunotherapy may get a boost by disabling specific T cells

September 7, 2017
Cancer immunotherapy drugs only work for a minority of patients, but a generic drug now used to increase blood flow may be able to improve those odds, a study by Columbia University Medical Center (CUMC) researchers suggests.

Study reveals how to reprogram cells in our immune system

August 2, 2017
When the immune system is imbalanced, either due to overly-active cells or cells that suppress its function, it causes a wide range of diseases, from psoriasis to cancer. By manipulating the function of certain immune cells, ...

Researchers makes 'natural born killer' cell discovery

August 31, 2017
An unexpected role for a white blood cell called the Natural Killer (NK) cell - a critical cell for ridding the body of infection and cancer, has been discovered by researchers at New Zealand's University of Otago.

Study sheds light on why some breast cancers have limited response to immunotherapy

August 21, 2017
UNC Lineberger Comprehensive Cancer Center researchers have identified a possible reason why some aggressive breast cancers are unresponsive to certain immunotherapy treatments, as well as a potential solution.

Partnering cells turn off immune attack on pancreatic tumors

July 18, 2017
Two cell types work together to protect pancreatic tumors from destruction by the immune system. But, blocking this partnership may restore the system's ability to attack these same tumor cells.

Identifying a novel target for cancer immunotherapy

April 12, 2017
Targeting a molecule called B7-H4—which blocks T-cells from destroying tumor cells—could lead to the development of new therapies that boost the immune system's ability to fight cancer, according to a review published ...

Recommended for you

New inflammation inhibitor discovered

November 16, 2018
A multidisciplinary team of researchers led from Karolinska Institutet in Sweden have developed an anti-inflammatory drug molecule with a new mechanism of action. By inhibiting a certain protein, the researchers were able ...

Pets can double as asthma antidote

November 16, 2018
(HealthDay)—The "hygiene hypothesis" holds that early exposure to a variety of microorganisms may decrease the risk for chronic inflammatory diseases, like asthma.

New study shows NKT cell subsets play a large role in the advancement of NAFLD

November 16, 2018
Since 2015 it has been known that the gut microbiota could have a direct impact on nonalcoholic fatty liver disease (NAFLD), which affects up to 12% of adults and is a leading cause of chronic liver disease. In the November ...

Defense against intestinal infection in organism is affected by prostaglandin E2

November 15, 2018
The treatment of intestinal infections caused by some strains of the bacterium Escherichia coli, present in unsanitized or contaminated foods, may have a new ally.

No link between 'hypoallergenic' dogs and lower risk of childhood asthma

November 15, 2018
Growing up with dogs is linked to a lower risk of asthma, especially if the dogs are female, a new study from Karolinska Institutet and Uppsala University in Sweden shows. However, the researchers found no relation between ...

Researchers finds better ways to improve the chances of survival of children with a rare immune deficiency

November 15, 2018
An international study published in the journal Blood by researchers led by Dr. Elie Haddad, a pediatric immunologist and researcher at CHU Sainte-Justine and professor at Université de Montréal, highlights the urgent need ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.